Thyroid Cancer Recurrence Risk Calculator (ATA Three-Tier System)
Answer from your pathology report and get your ATA recurrence risk tier. Skip anything your report doesn't mention:
Written and medically reviewed by Dr. Westin Childs, D.O. Last reviewed: August 28, 2026
How To Use This Calculator:
#1. Get Your Pathology Report
Everything this calculator asks comes from the pathology report you received after surgery. Tumor size, extension, lymph nodes, vascular invasion, and the variant are all listed there. If you can’t find something, your surgeon’s office can read it to you over the phone.
#2. Answer What You Know
Skip anything your report doesn’t mention. Most reports won’t have every detail, and the calculator works with what you give it.
#3. Read Your Tier
You’ll get low, intermediate, or high, the recurrence range that goes with it, and what each answer contributed. This is the same three-tier system your endocrinologist uses from the American Thyroid Association guidelines.[1]
#4. Bring The Questions To Your Doctor
The result includes a short list of questions matched to your tier, so your next appointment covers what actually matters for your follow-up.
Recurrence Risk Is Not Survival
Read this before you read your tier.
This calculator estimates the chance that some thyroid cancer comes back after treatment. It says nothing about survival, and that distinction matters, because survival with differentiated thyroid cancer is excellent in every tier, including high.[1]
A high recurrence risk means your care team watches you more closely and treats more aggressively up front. It doesn’t change what your disease is: one of the most treatable cancers there is.
And even when recurrence happens, it’s usually found early through the monitoring you’ll already be doing, and it’s usually treatable when it’s found.
What The Three Tiers Mean
- Low risk: cancer confined to the thyroid, completely removed, with at most a few tiny lymph node micrometastases. Recurrence is under about 5%.
- Intermediate risk: microscopic extension beyond the thyroid, more or larger involved lymph nodes, an aggressive variant, or vascular invasion. Recurrence is roughly 5 to 20%.
- High risk: gross extension into nearby structures, incomplete removal, distant spread, a lymph node 3 cm or larger, or extensive vascular invasion in follicular cancer. Recurrence is above 20%, and in some studies closer to half.[2]
Your tier decides your follow-up: how often you get ultrasounds and thyroglobulin labs, how suppressed your TSH is kept, and whether radioactive iodine gets recommended. That’s why knowing it is useful, and why your doctor should walk you through theirs.
One more thing: your tier isn’t permanent. After treatment, how you actually respond matters more than where you started, which is what dynamic risk assessment tracks at every follow-up visit.[3]
Frequently Asked Questions
No. High risk means a higher chance the cancer comes back and needs more treatment, so your team monitors you more closely. Survival with differentiated thyroid cancer stays excellent across all three tiers. Recurrence and survival are different questions, and this tool only answers the first one.
Staging (like Stage I or II) estimates survival and leans heavily on your age. The ATA three-tier system estimates the chance of the cancer coming back. Two people with the same stage can have different recurrence tiers. For day-to-day follow-up decisions, the recurrence tier does most of the work.
Your surgical pathology report. Ask your surgeon’s or endocrinologist’s office for a copy if you don’t have one. The items to look for: tumor size, extrathyroidal extension, margins, lymph node count and size, vascular invasion, and the variant (like tall cell).
Yes, and usually for the better. Your initial tier gets updated at every follow-up based on how you responded to treatment: your thyroglobulin trend and your imaging. An initially intermediate-risk patient with an excellent response ends up with a recurrence risk close to a low-risk patient’s.
Related Calculators
- Thyroid Cancer Staging Calculator: your AJCC stage from the same report
- Calcitonin & CEA Doubling Time Calculator: for medullary thyroid cancer surveillance
- All Thyroid Calculators & Quizzes: the full set of free tools
Scientific References
- Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133.
- Tuttle RM, Tala H, Shah J, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid. 2010;20(12):1341-1349.
- Momesso DP, Tuttle RM. Update on differentiated thyroid cancer staging. Endocrinol Metab Clin North Am. 2014;43(2):401-421.